Clinical Trial Update: Autologous Transplant for Multiple Myeloma [Phase 2, Phase 3]

View source ↗

Summary

A completed phase 2/3 trial evaluating autologous transplant for multiple myeloma with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Multiple Myeloma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-11-09